CrossrefInfokarte
Chemoimmunotherapy‐associated CD20 ( MS4A1 ) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies
HemaSphere · 2026-10 · 10 (10)
DOI: 10.1002/hem3.70468 ↗Abstract
Kein Abstract verfügbar.
EUVIMED